Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7514410 Hepatitis C therapies

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Pooran Chand0

Tsu-Hsing Lin0

V. Satish Kumar0

Yahya El-Kattan0

Yarlagadda S. Babu0

Pravin L. Kotian0

Ajit K. Ghosh0

Minwan Wu0

Date of Patent

April 7, 2009

0

Patent Application Number

113880600

Date Filed

March 23, 2006

0

Patent Citations Received

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

0

US Patent 11707480 Highly active compounds against COVID-19

0

US Patent 11780844 Compounds and methods for treatment of viral infections

US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections

0

US Patent 11903953 Remdesivir treatment methods

0

US Patent 11926645 Compounds and methods for treatment of viral infections

0

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

0

US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

0

...

Patent Primary Examiner

Patrick T. Lewis

0

Patent abstract

The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7514410 Hepatitis C therapies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool